Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Solifenacin and Tamsulosin, Atc Code: G04ca53 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Bismuth Subcitrate, Tetracycline, Metronidazole, Atc Code: A02bd08 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130C Paragraph 1 Sgb V for Barictinib, Atc Code: L04aa37 for the Period from 09/01/2023 to 08/31/2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Fluorouracil, Atc Code: L01bc02 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 or § 130C Paragraph 1 Sgb V for Evinacumab, Atc Code: C10ax for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130C Paragraph 1 Sgb V for Ribociclib, Atc Code: L01ef02 for the Period from 09/01/2023 to 08/31/2025

Oh-Biologika-2023-23 Insulin Glargine (Potency: 100 U/Ml)

Drug Contracts with Option to Join - 0050-Rvbeitr.63-2023

Completion of a Non-Excl. Discount Agreement According to § 130A Para. 8 Sgb V for Colistimethat Sodium, Atc Code: J01xb01 for the Period from September 1St, 2023 to August 31St, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Clindamycin, Atc Code: G01aa10 for the Period from September 1St, 2023 to August 31St, 2025